ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
1541
Rank in Stocks
#19268
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. is a biotechnology firm primarily... ImmuneOnco Biopharmaceuticals (Shanghai) Inc. is a biotechnology firm primarily dedicated to advancing immunotherapeutic treatments for various cancers. At the forefront of its development pipeline is IMM01, a CD47-targeting molecule currently undergoing clinical investigation. This lead candidate is being evaluated for its efficacy across a broad spectrum of malignancies, including myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), chronic myelomonocytic leukemia (CMML), classical Hodgkin lymphoma (cHL), non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), head and neck squamous cell carcinomas (HNSCC), and colorectal cancer (CRC). Beyond its primary program, the company boasts a robust portfolio of experimental therapies. These comprise IMM0306, a bispecific CD47×CD20 molecule aimed at relapsed/refractory B-cell non-Hodgkin lymphoma (B-NHL); IMM2902, another bispecific agent combining CD47 and HER2 for solid tumors that are either HER2-positive or HER2-low expressing; and IMM2520, a bispecific CD47×PD-L1 molecule intended for various solid tumors. Further development efforts include IMM47, a humanized monoclonal antibody designed to target CD24 for cancer treatment; MM4701, a distinct bispecific molecule simultaneously engaging both CD47 and CD24; IMM2510, a bispecific "mAb-Trap" engineered to block both VEGF and PD-L1; IMM27M, a CTLA-4 antibody enhanced for ADCC activity; and IMM40H, a humanized IgG1 CD70 monoclonal antibody also featuring augmented ADCC activity. The company was established in 2015 and is headquartered in Shanghai, China.
Share Price
$0.38122017
Last synced: 2026-10-16
Market Cap
$159.74M
Change (1 day)
2.58%
Change (1 year)
-71.65%
Country
CN
Trade ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541)
Category
Healthcare
Market Capitalization of ImmuneOnco Biopharmaceuticals (Shanghai) Inc.(1541)
Market Cap: $159.74M
As of October 2026 ImmuneOnco Biopharmaceuticals (Shanghai) Inc. has a market cap of $159.74M. This makes ImmuneOnco Biopharmaceuticals (Shanghai) Inc. the world's 19268th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. from 2023 to 2026
1541 compared with Top 5 Most Popular stocks
